Reactivation of brucellosis after treatment with infliximab in a patient with rheumatoid arthritis.
Jiménez
F G
FG
Colmenero
J D
JD
Irigoyen
M V
MV
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D002006:Brucellosis / Q000209:etiology*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab